Showing results (71-80 of 295) with videos related to

Sort By:
Pageof 30
Frontiers in Oncology|October 7, 2015
Dosimetric Effects of the Interfraction Variations during Whole Breast Radiotherapy: A Prospective StudyJulian Jacob, Steve Heymann, Isabelle Borget, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 29, 2025
External irradiation treatment process: 2025 updateQuentin Duhoux, Vincent Marchesi, Fabrice Lorchel, et al.
Bulletin Du Cancer|October 30, 2007
[Combination of anti-EGFR and anti-HER2 antibodies: hope in pancreatic cancer treatment]Christel Larbouret, Bruno Robert, Isabelle Teulon, et al.
Frontiers in Oncology|February 2, 2023
Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapyJessica Prunaretty, Celine Bourgier, Sophie Gourgou, et al.
Frontiers in Immunology|January 29, 2019
Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other ContributorsAlexandre Thibault Jacques Maria, Léo Partouche, Radjiv Goulabchand, et al.
European Journal of Cancer (Oxford, England : 1990)|January 15, 2013
Targeted therapy-induced radiation recallAntonin Levy, Antoine Hollebecque, Céline Bourgier, et al.
The Oncologist|August 19, 2018
Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor BiologyGaia Griguolo, Stephane Pouderoux, Maria Vittoria Dieci, et al.
Gastroenterology Research and Practice|October 9, 2015
Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric JunctionLaurence Moureau-Zabotto, Eric Teissier, Didier Cowen, et al.
Radiation Oncology (London, England)|July 22, 2011
Eight years of IMRT quality assurance with ionization chambers and film dosimetry: experience of the Montpellier Comprehensive Cancer CenterPascal Fenoglietto, Benoit Laliberté, Norbert Aillères, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2014
Resistance to human epidermal growth factor receptor type 2-targeted therapiesJean-Christophe Thery, Jean-Philippe Spano, David Azria, et al.
Pageof 30